Hepion Pharmaceuticals (HEPA) Stock Chart & Stock Price History → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free HEPA Stock Alerts $1.17 -0.13 (-10.00%) (As of 05/20/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Hepion Pharmaceuticals Stock Price Performance5 Day Performance+0.86%1 Month Performance-41.79%3 Month Performance-52.82%6 Month Performance-62.86%Year-To-Date Performance-63.89%1 Year Performance-86.81% Receive HEPA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchWhat President Biden's new law means for investorsWhat's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. HEPA Stock Chart for Tuesday, May, 21, 2024 HEPA Chart by TradingView Hepion Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2024$1.30$1.17-10.00%$1.30$1.1533,388 shs$6.40 million05/17/2024$1.24$1.30+4.84%$1.35$1.2028,040 shs$7.11 million05/16/2024$1.16$1.24+6.90%$1.25$1.1232,125 shs$6.79 million05/15/2024$1.29$1.16-10.08%$1.33$1.1281,065 shs$6.35 million05/14/2024$1.19$1.29+8.40%$1.31$1.1849,437 shs$7.06 million05/13/2024$1.26$1.19-5.56%$1.26$1.1835,436 shs$6.51 million Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/10/2024$1.32$1.26-4.55%$1.38$1.1989,446 shs$6.89 million05/09/2024$1.31$1.32+0.76%$1.40$1.3015,060 shs$7.22 million05/08/2024$1.37$1.31-4.38%$1.55$1.3077,695 shs$7.17 million05/07/2024$1.38$1.37-0.72%$1.44$1.3012,853 shs$7.49 million05/06/2024$1.46$1.38-5.48%$1.54$1.3834,402 shs$7.55 million05/03/2024$1.52$1.46-3.95%$1.59$1.4632,548 shs$7.99 million05/02/2024$1.36$1.52+11.76%$1.55$1.3741,718 shs$8.31 million05/01/2024$1.37$1.36-0.37%$1.40$1.346,132 shs$7.44 million04/30/2024$1.38$1.37-1.09%$1.41$1.339,096 shs$7.47 million04/29/2024$1.37$1.38+0.73%$1.44$1.3420,232 shs$7.55 million04/26/2024$1.29$1.37+6.20%$1.44$1.2739,627 shs$7.49 million04/25/2024$1.32$1.29-2.27%$1.35$1.2722,992 shs$7.06 million04/24/2024$1.49$1.32-11.41%$1.54$1.3037,310 shs$7.22 million04/23/2024$1.41$1.49+5.67%$1.52$1.2970,728 shs$8.15 million04/22/2024$2.01$1.41-29.85%$1.60$1.22321,558 shs$7.71 million04/19/2024$2.05$2.10+2.44%$2.20$2.05131,814 shs$11.49 million04/18/2024$2.04$2.05+0.49%$2.21$2.0427,949 shs$8.90 million04/17/2024$2.04$2.04$2.21$2.0021,541 shs$8.85 million04/16/2024$2.18$2.04-6.42%$2.22$2.0425,712 shs$8.85 million04/15/2024$2.19$2.18-0.46%$2.35$2.1610,027 shs$9.46 million04/12/2024$2.27$2.19-3.52%$2.30$2.1816,941 shs$9.50 million04/11/2024$2.33$2.27-2.58%$2.35$2.0834,460 shs$9.85 million04/10/2024$2.44$2.33-4.51%$2.46$2.2535,130 shs$10.11 million04/09/2024$2.56$2.44-4.69%$2.56$2.3817,724 shs$10.59 million04/08/2024$2.52$2.56+1.59%$2.61$2.4716,226 shs$11.11 million04/05/2024$2.64$2.52-4.55%$2.64$2.4929,976 shs$10.94 million04/04/2024$2.56$2.64+3.13%$2.90$2.41122,307 shs$11.46 million04/03/2024$2.29$2.56+11.79%$2.56$2.2545,510 shs$11.11 million04/02/2024$2.36$2.29-2.97%$2.39$2.2226,580 shs$9.94 million04/01/2024$2.49$2.36-5.22%$2.45$2.3139,470 shs$10.24 million03/29/2024$2.49$2.49$2.53$2.4221,291 shs$10.81 million03/28/2024$2.50$2.49-0.40%$2.53$2.4221,288 shs$10.81 million03/27/2024$2.32$2.50+7.76%$2.56$2.2251,656 shs$10.85 million03/26/2024$2.28$2.32+1.75%$2.41$2.2532,817 shs$10.07 millionNext President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________.03/25/2024$2.35$2.28-2.98%$2.37$2.218,445 shs$9.90 million03/22/2024$2.32$2.35+1.29%$2.42$2.0525,899 shs$10.20 million03/21/2024$2.34$2.32-0.85%$2.33$2.2014,562 shs$10.07 million03/20/2024$2.13$2.34+9.86%$2.35$2.0512,441 shs$10.16 million03/19/2024$2.18$2.13-2.29%$2.29$2.0724,604 shs$9.24 million03/18/2024$2.26$2.18-3.54%$2.21$2.0745,771 shs$9.46 million03/15/2024$2.03$2.26+11.33%$2.36$1.9640,719 shs$9.81 million03/14/2024$2.09$2.03-2.87%$2.31$1.8950,387 shs$8.81 million03/13/2024$2.18$2.09-4.13%$2.44$2.0274,556 shs$9.07 million03/12/2024$2.24$2.18-2.68%$2.24$2.0828,722 shs$9.46 million03/11/2024$2.35$2.24-4.68%$2.38$2.1525,323 shs$9.72 million03/08/2024$2.27$2.37+4.41%$2.55$2.2645,603 shs$10.29 million03/07/2024$2.29$2.27-0.87%$2.43$2.2328,252 shs$9.85 million03/06/2024$2.60$2.29-11.92%$2.68$2.16107,042 shs$9.94 million03/05/2024$2.83$2.60-8.13%$2.93$2.5260,869 shs$11.28 million03/04/2024$3.17$2.83-10.73%$3.18$2.8350,155 shs$12.28 million03/01/2024$2.97$3.17+6.73%$3.33$3.0092,556 shs$13.76 million02/29/2024$2.75$2.97+8.00%$3.07$2.7970,898 shs$12.89 million02/28/2024$2.39$2.75+15.06%$2.82$2.34105,463 shs$11.94 million02/27/2024$2.33$2.39+2.58%$2.48$2.3057,342 shs$10.37 million02/26/2024$2.42$2.33-3.72%$2.59$2.2645,200 shs$10.11 million02/23/2024$2.45$2.42-1.22%$2.59$2.3099,946 shs$10.50 million02/22/2024$2.26$2.45+8.41%$2.60$2.1775,227 shs$10.63 million02/21/2024$2.48$2.26-8.87%$2.47$2.0753,875 shs$9.81 million02/20/2024$2.56$2.48-3.13%$3.05$2.3354,695 shs$10.76 million02/19/2024$2.56$2.56$3.49$2.04427,100 shs$11.11 million Related Companies: CVKD Stock Price Chart SHPH Stock Price Chart KTTA Stock Price Chart TENX Stock Price Chart VCNX Stock Price Chart VIRI Stock Price Chart OGEN Stock Price Chart EFTR Stock Price Chart IBIO Stock Price Chart CANF Stock Price Chart Receive HEPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HEPA) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.